Next steps
Publication: The Role of the FBXW2 Enzyme as a Potential Modulator of NF-κB Activity and Its Influence on the HER2+ to Triple-Negative Subtype Transition in Breast Cancer
Next steps
Publication: THE BASAL SUBTYPE HAS HIGHER mRNA LEVEL EXPRESSION OF THE TNF-alpha PATHWAY THAN THE LUMINAL SUBTYPE IN BREAST CANCER SAMPLES.
Next steps
Publication: GENETIC POLYMORPHISMS IN THE VDR GENE AND THEIR INFLUENCE ON NATALIZUMAB RESPONSE IN MULTIPLE SCLEROSIS PATIENTS
Question
Publication: INTERFERENCE RNA FOR PERSONALIZED CANCER THERAPY: WHERE ARE WE NOW?
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper